Pharmacy · Finance
The numbers behind a healthy pharmacy: what owners should watch monthly
A handful of numbers, checked every month, reveal whether a pharmacy is genuinely healthy or just busy. Here is what they are, where margin actually comes from, and the pattern we see most often once we benchmark them.
A healthy pharmacy is visible in five numbers, checked monthly rather than at year-end: the split between NHS and private income, your actual retained margin rather than the national average, stock turnover and cash tied up in inventory, staff costs as a percentage of income, and whether you are consistently hitting the volume thresholds that unlock NHS service payments. Most pharmacy owners we meet are tracking dispensing volume closely and these five numbers barely at all, which is exactly where margin quietly leaks.
At a glance
| Number | What it reveals | Red flag |
|---|---|---|
| NHS vs private income split | How exposed you are to NHS funding and settlement timing | Private and services income static or shrinking as a share of the total |
| Retained margin % (actual) | Whether your buying is genuinely profitable, not just assumed to be | Actual margin running below the national average with no explanation |
| Stock turnover & cash tied up | How much working capital is sitting on shelves instead of in the bank | Rising stock value alongside flat or falling sales |
| Staff cost as % of income | Whether your biggest cost is scaling with income or outpacing it | Staff costs growing faster than total income for two or more months running |
| NHS service volume vs thresholds | Whether you’re actually earning every payment you’re entitled to | Sitting near, at, or just under a minimum consultation threshold |
The income streams: NHS, private, and services
Most pharmacies still sit heavily on NHS funding
For most community pharmacies, NHS funding still makes up the large majority of income, commonly around 90-95%, with private sales, over-the-counter retail, and clinical services making up the rest. Each stream behaves differently, and a healthy pharmacy tracks them separately rather than as one blended “turnover” figure.
NHS income itself splits into several distinct pieces worth separating in your own reporting: dispensing fees, retained buying margin, Pharmacy First and other Advanced Service payments, and fixed monthly payments like the establishment and practice payments that all contracted pharmacies receive regardless of volume. The 2026/27 Community Pharmacy Contractual Framework settlement increased total national funding to £3.636 billion, up £340 million on the previous year, with the single activity fee rising from £1.46 to £1.52 per item. Those are the figures for the English contract: Scotland, Wales and Northern Ireland each run their own settlement, though the mechanics in this article apply everywhere. And a national uplift doesn’t automatically mean your pharmacy’s income has moved by the same proportion.
Where margin comes from, and where it leaks
Not a retail markup: a reimbursement gap
Most pharmacy margin doesn’t come from a retail-style markup: it comes from the gap between what the NHS reimburses you for a medicine (based on the Drug Tariff) and what you actually paid your wholesaler for it. That gap is called retained buying margin, and it’s much more volatile than most owners assume.
Reimbursement is set nationally and moves slowly. Your actual purchase price moves constantly: generic drug prices shift month to month, wholesaler terms change, and short-dated stock sometimes has to be bought at less favourable prices under time pressure. The margin allowance nationally increased to £1.1 billion for 2026/27, up £200 million, but that’s a sector-wide figure distributed on collective purchasing performance, not a guarantee that any individual pharmacy’s margin has improved by the same measure.
Stock and cash tied up
A two-month reimbursement lag most retail businesses don’t have
Pharmacies carry unusually large and varied stock ranges by necessity, and the combination of that stock volume with an NHS reimbursement cycle that lags behind dispensing by roughly two months creates a cash flow gap most other retail businesses don’t face.
You have paid your wholesaler for the medicine, dispensed it to the patient, and submitted the prescription, but the NHS reimbursement for that item doesn’t land for weeks. Multiply that lag across thousands of items a month and it’s easy to see how a pharmacy can look profitable on paper while genuinely struggling for cash, particularly if stock levels are creeping up at the same time.
The KPIs pharmacy owners should watch monthly
The five headline numbers expand into eight KPIs worth tracking in full. Checked every month rather than reconstructed at year-end, they cover almost everything that determines whether a pharmacy is genuinely healthy or just busy.
These are exactly the figures we build into monthly management accounts for pharmacy clients, specifically because a once-a-year set of statutory accounts shows none of this until it’s already history.
Client pattern: margin leaks owners couldn’t see
Two patterns that repeat across pharmacy clients
A pattern that comes up more often than most owners expect: a pharmacy assumes its retained margin is roughly in line with the national average, because that’s the figure everyone in the sector refers to. Once we reconcile actual NHS reimbursement schedules against actual wholesaler invoices, line by line, the real figure is often running a couple of percentage points below what was assumed, not because of anything the owner did wrong but because generic price movements between ordering and dispensing had quietly eroded it in ways no single monthly statement made obvious. A gap that size compounds quickly: two percentage points on £500,000 of annual NHS dispensing is £10,000 of profit that never arrives, invisible until the two figures are actually placed side by side.
A second pattern we see just as often involves Pharmacy First and other Advanced Service thresholds: a pharmacy sitting consistently just under the minimum monthly consultation count required for a payment, losing the entire month’s payment rather than a partial amount, without anyone flagging the volume gap until well after the period has closed.
Both patterns share the same root cause: the numbers existed. Nobody was checking them monthly.
When do the numbers say you need help?
When your margin percentage has been assumed rather than reconciled for more than a year, when stock value is rising without a clear explanation, or when you genuinely don’t know whether last month’s NHS payment matched what you were owed, it’s time for a proper review rather than another year of the same assumptions.
None of this means something has gone wrong. It usually means the numbers have simply outgrown a bookkeeping setup built for compliance rather than insight: accounts filed correctly and on time, with nobody looking closely enough, monthly, to catch the smaller gaps before they compound. If your pharmacy operates as a limited company, it’s also worth remembering that proper monthly reconciliation feeds directly into cleaner, faster year-end statutory filing: the two aren’t separate jobs, one just happens twelve times more often than the other.
Frequently asked questions
What is retained buying margin in a pharmacy?
It’s the difference between what the NHS reimburses you for a medicine, based on the Drug Tariff, and what you actually paid your wholesaler for it. It’s the core source of pharmacy profitability on NHS dispensing, and it moves more than most owners assume as generic prices and wholesaler terms shift.
Why does my pharmacy’s NHS payment lag behind what I dispensed?
NHS reimbursement is processed on a schedule that typically runs around two months behind the point of dispensing, since prescriptions have to be submitted, processed, and priced before payment is made. This lag is normal, but cash flow planning needs to account for it explicitly.
How much stock should a pharmacy carry?
There’s no single right figure: it depends on your patient base, prescribing patterns, and wholesaler delivery frequency. But the trend matters more than the absolute level. Stock value rising faster than sales, or turnover slowing month on month, is the signal worth acting on.
What percentage of pharmacy income should come from NHS versus private?
Most community pharmacies sit heavily towards NHS income, commonly in the 90-95% range, and there’s nothing inherently wrong with that. What matters more is tracking whether your private and services income is growing, static, or shrinking as its own trend.
How often should I actually review these numbers?
Monthly, at minimum. Margin, stock, and service-threshold problems are all far cheaper to fix when caught within a month or two than when discovered at year-end, by which point a small, correctable gap has often become a much larger one.
See what your own numbers are actually doing
If you’re currently working from the national averages rather than your own reconciled figures, it’s worth finding out what the real numbers say before another year passes.
No obligation, same-day response. Or call us now on 01224 042961.
